New multi-stakeholder collaboration will drive dialogue on specificities of clinical standards for medical technology
The European Forum for Good Clinical Practice (EFGCP) and MedTech Europe, the alliance of European medical technology industry associations, today announce the establishment of a joint Medical Technology. Working Party within EFGCP aimed at addressing ethical and quality issues when setting standards for clinical evaluation in the medical technology sector.
Setting effective ethical and quality clinical standards for medical technology is critical to ensuring that patients have access to safe and effective treatment. The joint EFGCP-MedTech Europe “Medical Technology Working Party” will seek to involve stakeholders in a dialogue on making sure these standards are broadly accepted and reliably introduced in the rapidly developing, diverse medical technology landscape.
“Historically, the clinical development debate has focused on pharmaceuticals,” said EFGCP Chair Ingrid Klingmann, “but it’s important that we have a deeper conversation about issues that need to be considered when setting standards for the medical technology sector.”
The working party hopes to attract a broad group of expert stakeholders including patient advocates, physician groups, academics, ethics committees, competent authorities and medtech and pharma industry representatives to collect views on good clinical practice, quality and ethical issues as they pertain to medical technology and provide recommendations to policy-makers. MedTech Europe CEO Serge Bernasconi said: “There’s a growing understanding in the healthcare policy arena that we can’t just copy and paste the pharmaceutical approach to clinical standards into EU legislation on medical devices and in vitro diagnostics. Only with a vibrant dialogue can we figure out which direction is right for medical technology and above all, for the patient.”
The working group will initially organise a joint workshop on Mitigating Risks in the Lifecycle of Medical Devices: Options and Challenges in the Medical Device Legislation. The workshop, to be held on 4 December in Brussels, will bring together patients, national competent authorities, ethics committees, lab technicians, healthcare professionals, industry representatives and European regulatory authorities with the aim of finding consensus on key topics of interest and potential policy recommendations.
There will be a separate discussion specifically on in vitro diagnostics and particular considerations related to the proposed IVD Regulation, with the view to organising a high-level, multi-stakeholderroundtable and assess the key concerns.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.